4D Molecular Therapeutics saw the highest growth of 99% in patent filings and 99% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 99% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of 4D Molecular Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

4D Molecular Therapeutics has been focused on protecting inventions in United States(US) with three publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 60% filings and 0% grants. The United States(US), European Patent Office(EPO), South Korea(KR), and Ukraine(UA) patent Office are among the top ten patent offices where 4D Molecular Therapeutics is filings its patents. Among the top granted patent authorities, 4D Molecular Therapeutics has 100% of its grants in Ukraine(UA)

Patents related to rare diseases and genomics lead 4D Molecular Therapeutics's portfolio

4D Molecular Therapeutics has the highest number of patents in rare diseases followed by, genomics. For rare diseases, nearly 67% of patents were filed and no patents were granted in Q1 2024.

Macular degeneration related patents lead 4D Molecular Therapeutics portfolio followed by cryopyrin-associated periodic syndromes, and behcet disease

4D Molecular Therapeutics has highest number of patents in macular degeneration followed by cryopyrin-associated periodic syndromes, behcet disease, proliferative vitreoretinopathy (pvr), and wet (neovascular / exudative) macular degeneration.

For comprehensive analysis of 4D Molecular Therapeutics's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.